IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial-stage biotechnology company with a focus in oncology, announced today that an overview of the Company’s business strategy will be presented at the UBS Global Life Sciences Conference on Wednesday, September 23, 2009 at 4:00pm Eastern Time. The conference is being held at the Grand Hyatt New York Hotel in New York City.
